JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy

A new mathematical model for relative quantification in real-time RT-PCR

Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · see citing works

Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects

Florea, A.-M., & Büsselberg, D. (2011) · Cancers · doi:10.3390/cancers3011351 · Cited by 1,759 · see citing works

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A., Selley, D. E., Parsons, L. H., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 938 · see citing works

Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation

Nomura, D. K., Morrison, B. E., Blankman, J. L., Long, J. Z., Kinsey, S. G., Marcondes, M. C. G., Ward, A. M., Hahn, Y. K., Lichtman, A. H., Conti, B., et al. (2011) · Science · doi:10.1126/science.1209200 · Cited by 727 · see citing works

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2616 · Cited by 641 · see citing works

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571 · see citing works

Cannabinoid CB ₂ receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423 · see citing works

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works

Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630

Ross, R. A., Brockie, H. C., Stevenson, L., Murphy, V. L., Templeton, F., Makriyannis, A., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702351 · Cited by 407 · see citing works

CB2 cannabinoid receptor-mediated peripheral antinociception

Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391 · see citing works

Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide

Gonsiorek, W., Lunn, C. A., Fan, X., Narula, S. K., Lundell, D. J., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 370 · see citing works

Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.

Gregg, R. W., Molepo, J. M., Monpetit, V. J., Mikael, N. Z., Redmond, D., Gadia, M., & Stewart, D. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.795 · Cited by 359 · see citing works

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

SUGIURA, T., KISHIMOTO, S., OKA, S., & Gokoh, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.003 · Cited by 356 · see citing works

Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · see citing works

Sensory and Signaling Mechanisms of Bradykinin, Eicosanoids, Platelet-Activating Factor, and Nitric Oxide in Peripheral Nociceptors

Pethö, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 288 · see citing works

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol

Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 255 · see citing works

Crucial Role of CB₂Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Manzanares, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3400-08.2008 · Cited by 195 · see citing works

CB2 cannabinoid receptor mediation of antinociception

Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J. Y., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, P. T. (2006) · Pain · doi:10.1016/j.pain.2005.12.018 · Cited by 172 · see citing works

Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects

Kinsey, S. G., Wise, L. E., Ramesh, D., Abdullah, R., Selley, D. E., Cravatt, B. F., & Lichtman, A. H. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201426 · Cited by 169 · see citing works

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment

Guindon, J., Lai, Y., Takacs, S. M., Bradshaw, H. B., & Hohmann, A. G. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.013 · Cited by 160 · see citing works

Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists

Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 134 · see citing works

Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy

Khasabova, I. A., Khasabov, S., Paz, J., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0403-12.2012 · Cited by 129 · see citing works

The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model

Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127 · see citing works

Endocannabinoid tone versus constitutive activity of cannabinoid receptors

Howlett, A. C., Reggio, P. H., Childers, S. R., Hampson, R. E., Ulloa, N. M., & Deutsch, D. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01364.x · Cited by 126 · see citing works

Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor Mechanisms

Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118 · see citing works

Pain in oxaliplatin-induced neuropathy – Sensitisation in the peripheral and central nociceptive system

Binder, A., Stengel, M., Maag, R., Wasner, G. L., Schoch, R., Moosig, F., Schommer, B., & Baron, R. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.030 · Cited by 104 · see citing works

The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation

Comelli, F., Giagnoni, G., Bettoni, I., Colleoni, M., & Costa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707425 · Cited by 97 · see citing works

The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB₂ Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy

Deng, L., Guindon, J., Vemuri, V. K., Thakur, G. A., White, F. A., Makriyannis, A., & Hohmann, A. G. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-71 · Cited by 94 · see citing works

Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand

Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 90 · see citing works

A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain

Khasabova, I. A., Khasabov, S. G., Harding-Rose, C., Coicou, L. G., Seybold, B., Lindberg, A. E., Steevens, C. D., Simone, D. A., & Seybold, V. S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2847-08.2008 · Cited by 90 · see citing works

Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

Jhaveri, M. D., Sagar, D. R., Elmes, S. J. R., Kendall, D. A., & Chapman, V. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8007-7 · Cited by 89 · see citing works

Hyperalgesic priming in the rat demonstrates marked sexual dimorphism

Joseph, E. K., Parada, C. A., & Levine, J. D. (2003) · Pain · doi:10.1016/s0304-3959(03)00175-1 · Cited by 88 · see citing works

Anandamide uptake explained?

Fowler, C. J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.001 · Cited by 85 · see citing works

Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

Davis, M. P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.1.85 · Cited by 82 · see citing works

Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain

Khasabova, I. A., Chandiramani, A., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.007 · Cited by 75 · see citing works

Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy

Vera, G., Cabezos, P. A., Martín, M. I., & Abalo, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.02.008 · Cited by 68 · see citing works

Peroxisome Proliferator-Activated Receptor α Mediates Acute Effects of Palmitoylethanolamide on Sensory Neurons

Khasabova, I. A., Xiong, Y., Coicou, L. G., Piomelli, D., & Seybold, V. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0130-12.2012 · Cited by 64 · see citing works

Chemical Interactions between Fibrosarcoma Cancer Cells and Sensory Neurons Contribute to Cancer Pain

Khasabova, I. A., Stucky, C. L., Harding-Rose, C., Eikmeier, L., Beitz, A. J., Coicou, L. G., Hanson, A. E., Simone, D. A., & Seybold, V. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2851-07.2007 · Cited by 62 · see citing works

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

Rahn, E. J., Thakur, G. A., Wood, J. A. T., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.024 · Cited by 57 · see citing works

CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain

Khasabova, I. A., Gielissen, J. M., Chandiramani, A., Harding-Rose, C., Odeh, D. A., Simone, D. A., & Seybold, V. S. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283474a6d · Cited by 53 · see citing works

Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors

Desroches, J., Charron, S., Bouchard, J., & Beaulieu, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.006 · Cited by 51 · see citing works

Mode of action of cannabinoids on nociceptive nerve endings

Kress, M., & Kuner, R. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1762-0 · Cited by 49 · see citing works

Primary culture of trigeminal satellite glial cells: a cell-based platform to study morphology and function of peripheral glia.

Poulsen, J. N., Larsen, F., Duroux, M. C., & Gazerani, P. (2014) · Europe PMC (PubMed Central) · Cited by 37 · see citing works

Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain

Khasabova, I. A., Holman, M. A., Morse, T., Burlakova, N., Coicou, L. G., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.018 · Cited by 26 · see citing works

Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord

Horváth, E., Woodhams, S. G., Nyilas, R., Henstridge, C. M., Kano, M., Sakimura, K., Watanabe, M., & Katona, I. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12470 · Cited by 18 · see citing works

Effects of fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice

Teicher, B. A., Holden, S. A., & Crawford, J. M. (1988) · Cancer · doi:10.1002/1097-0142(19880601)61:11 · Cited by 13 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research

Leitzelar, B. N., & Koltyn, K. F. (2021) · Sports Medicine - Open · doi:10.1186/s40798-021-00307-9 · Cited by 84 · see citing works

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

Khasabova, I. A., Khasabov, S. G., Olson, J. K., Uhelski, M. L., Kim, A. H., Albino-Ramírez, A. M., Wagner, C. L., Seybold, V. S., & Simone, D. A. (2018) · Pain · doi:10.1097/j.pain.0000000000001448 · Cited by 72 · see citing works

Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain

Blanton, H. L., Brelsfoard, J., Deturk, N., Pruitt, K., Narasimhan, M., Morgan, D. J., & Guindon, J. (2019) · Drugs · doi:10.1007/s40265-019-01132-x · Cited by 70 · see citing works

Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment

Mattar, M., Umutoni, F., Hassan, M. A., Wamburu, M. W., Turner, R., Patton, J. S., Chen, X., & Lei, W. (2024) · Life · doi:10.3390/life14080991 · Cited by 69 · see citing works

Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States

Lowy, D. B., Makker, P. G. S., & Moalem‐Taylor, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660203 · Cited by 69 · see citing works

Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors

Tabrizi, M. A., Baraldi, P. G., Baraldi, S., Ruggiero, E., Stefano, L. D., Rizzolio, F., Mannelli, L. D. C., Ghelardini, C., Chicca, A., Lapillo, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01845 · Cited by 60 · see citing works

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation

Mulpuri, Y., Marty, V. N., Munier, J. J., Mackie, K., Schmidt, B. L., Seltzman, H. H., & Spigelman, I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.002 · Cited by 62 · see citing works

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain

Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 52 · see citing works

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models

Masocha, W. (2018) · Pain Research and Management · doi:10.1155/2018/5234943 · Cited by 37 · see citing works

2-arachidonyl glycerol modulates astrocytic glutamine synthetase via p38 and ERK1/2 pathways

Wang, S., Zhang, H., Geng, B., Xie, Q., Li, W., Deng, Y., Shi, W., Pan, Y., Kang, X., & Wang, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1254-x · Cited by 33 · see citing works

Endocannabinoid and Prostanoid Crosstalk in Pain

Buisseret, B., Alhouayek, M., Guillemot‐Legris, O., & Muccioli, G. G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.009 · Cited by 30 · see citing works

Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-α) expression

Abdel-Razek, E. A.-N., Abo‐Youssef, A. M., & Azouz, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117272 · Cited by 30 · see citing works

Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain

Thomas, A., Okine, B. N., Finn, D. P., & Masocha, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110456 · Cited by 29 · see citing works

Evaluation of different drug classes on transient sciatic nerve injury–depressed marble burying in mice

Wilkerson, J. L., Curry, Z. A., Kinlow, P. D., Mason, B. L., Hsu, K., van der Stelt, M., Cravatt, B. F., & Lichtman, A. H. (2018) · Pain · doi:10.1097/j.pain.0000000000001199 · Cited by 26 · see citing works

Amlodipine alleviates cisplatin-induced nephrotoxicity in rats through gamma-glutamyl transpeptidase (GGT) enzyme inhibition, associated with regulation of Nrf2/HO-1, MAPK/NF-κB, and Bax/Bcl-2 signaling

Azouz, A. A., Abdel-Razek, E. A.-N., & Abo‐Youssef, A. M. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.08.022 · Cited by 27 · see citing works

Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy

Warren, W. G., Osborn, M., Tsantoulas, C., David-Pereira, A., Cohn, D., Duffy, P., Ruston, L., Johnson, C. T., Bradshaw, H. B., Kaczocha, M., et al. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.01.335 · Cited by 26 · see citing works

Peripherally Restricted Cannabinoids for the Treatment of Pain

Romero-Sandoval, E. A., Asbill, S., Paige, C. A., & Byrd-Glover, K. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1642 · Cited by 26 · see citing works

Update on cannabis and cannabinoids for cancer pain

Chung, M. J., Kim, H. K., & Abdi, S. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000934 · Cited by 24 · see citing works

Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review

Aly, E., & Masocha, W. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.01.004 · Cited by 22 · see citing works

Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences

Noya-Riobó, M. V., Miguel, C. Á., Soriano, D., Brumovsky, P. R., Villar, M. J., & Coronel, M. F. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114232 · Cited by 20 · see citing works

Cannabinoid receptor 1 positive allosteric modulator (GAT229) attenuates cisplatin-induced neuropathic pain in mice

Bagher, A. M., Binmahfouz, L. S., Shaik, R. A., & Eid, B. G. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.12.011 · Cited by 20 · see citing works

Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models

Bagüés, A., López‐Tofiño, Y., Llorente‐Berzal, A., & Abalo, R. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000667 · Cited by 18 · see citing works

An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy‐induced peripheral neuropathy, based on preclinical studies in rodent models

Bouchenaki, H., Danigo, A., Sturtz, F. G., Hajj, R., Magy, L., & Demiot, C. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12617 · Cited by 18 · see citing works

Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease

Khasabova, I. A., Gable, J., Johns, M. E., Khasabov, S. G., Kalyuzhny, A. E., Golovko, M. Y., Golovko, S. A., Kiven, S. B., Gupta, K., Seybold, V. S., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280460 · Cited by 17 · see citing works

Spatial Transcriptomics Reveals Novel Mechanisms Involved in Perineural Invasion in Pancreatic Ductal Adenocarcinomas

Lakis, V., Chan, N. L., Lyons, R. J., Blackburn, N., Nguyen, T. H., Nguyen, T., Masel, A., Masel, A. M., Boyle, G. M., Patch, A., et al. (2025) · Cancers · doi:10.3390/cancers17050852 · Cited by 16 · see citing works

Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

Lafreniere, J. D., & Kelly, M. E. M. (2018) · Neuronal Signaling · doi:10.1042/ns20170144 · Cited by 15 · see citing works

Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research

Ramer, R., & Hinz, B. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108851 · Cited by 15 · see citing works

Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy

Dönertaş, B., Ünel, Ç. Ç., & Erol, K. (2018) · Journal of Experimental Pharmacology · doi:10.2147/jep.s162059 · Cited by 14 · see citing works

JZL184 protects hippocampal neurons from oxygen-glucose deprivation-induced injury via activating Nrf2/ARE signaling pathway

Xu, J., Guo, Q., Huo, K., Song, Y., Li, N., & Du, J. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120984220 · Cited by 10 · see citing works

Cannabinoid mechanisms contribute to the therapeutic efficacy of the kratom alkaloid mitragynine against neuropathic, but not inflammatory pain

Farkas, D. J., Inan, S., Heydari, L. N., Johnson, C. T., Zhao, P., Bradshaw, H. B., Ward, S. J., & Rawls, S. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121878 · Cited by 8 · see citing works

G Protein-Coupled Receptors and Ion Channels Involvement in Cisplatin-Induced Peripheral Neuropathy: A Review of Preclinical Studies

Becker, G., Atuati, S. F., & Oliveira, S. M. (2024) · Cancers · doi:10.3390/cancers16030580 · Cited by 8 · see citing works

Characterisation of the effects of the chemotherapeutic agent paclitaxel on neuropathic pain-related behaviour, anxiodepressive behaviour, cognition, and the endocannabinoid system in male and female rats

Marino, C. D., Llorente‐Berzal, A., Diego, A. M., Bella, A., Boullon, L., Berrocoso, E., Roche, M., & Finn, D. P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1505980 · Cited by 7 · see citing works

Antiallodynic effect of PhAR‐DBH‐Me involves cannabinoid and TRPV1 receptors

Quiñonez‐Bastidas, G. N., Palomino‐Hernández, O., López‐Ortíz, M., Rocha-­González, H. I., González‐Anduaga, G. M., Regla, I., & Navarrete, A. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.663 · Cited by 7 · see citing works

Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors

Paredes-Ruiz, K. J., Chavira-Ramos, K., Galván‐Arzate, S., Rangel‐López, E., Karasu, Ç., Túnez, I., Skalny, A. V., Ke, T., Aschner, M., Orozco‐Morales, M., et al. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00661-4 · Cited by 6 · see citing works

Modulation of Astrocytic Glutamine Synthetase by Endocannabinoid 2-Arachidonoylglycerol in JNK-Independent Pathway

Wang, J., Wang, S., & Zhang, H. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.682051 · Cited by 5 · see citing works

Modulation of Pain by Endocannabinoids in the Periphery

Uhelski, M. L., Khasabova, I. A., & Simone, D. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79673 · Cited by 5 · see citing works

MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice

Cataldo, G., Lunzer, M. M., Akgün, E., Wong, H. L., Portoghese, P. S., & Simone, D. A. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.02.006 · Cited by 4 · see citing works

Antinociceptive effect of salvinorin A from the extract of Salvia divinorum in formalin-evoked trigeminal pain behavior in mice: Underlying mechanisms

Quiñonez‐Bastidas, G. N., Tixta-Ramírez, E. D., Balderas-López, J. L., Vargas-Durán, P. A., Pérez‐Vásquez, A., & Navarrete, A. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120311 · Cited by 3 · see citing works

Levels of bioactive endogenous lipids and health-related quality of life in Chronic Idiopathic Axonal Polyneuropathy

Lind, J., Stensson, N., Gerdle, B. U. C., & Ghafouri, N. (2022) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v127.8577 · Cited by 2 · see citing works

The role of the endocannabinoid 2-arachidonoylglycerol in the in vivo spinal oxytocin-induced antinociception in male rats

Salinas-Abarca, A. B., Martı́nez-Lorenzana, G., Condés‐Lara, M., & González‐Hernández, A. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114383 · Cited by 2 · see citing works

The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats

López‐Tofiño, Y., Hopkins, M. A., Bagüés, A., Boullon, L., Abalo, R., & Llorente‐Berzal, A. (2024) · Pharmaceuticals · doi:10.3390/ph17101256 · Cited by 1 · see citing works

2-Arachodonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in micePreprint

Morgan, A., Adank, D. N., Johnson, K., Blunt, E., & Patel, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480609 · Cited by 1 · see citing works

MMG22 Potently Blocks Hyperalgesia in Cisplatin-Treated MicePreprint

Cataldo, G., Lunzer, M. M., Akgün, E., Wong, H. L., Portoghese, P. S., & Simone, D. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4192510 · Cited by 1 · see citing works

HUF-101, um análogo do canabidiol, previne a alodinia mecânica e térmica em modelo de dor neuropática periférica induzida por quimioterápico

da Silva, N. R. (2020) · doi:10.11606/t.17.2020.tde-18082020-212144

Spatial Transcriptomics of Perineural Invasion in Pancreatic Ductal AdenocarcinomasPreprint

Nones, K., Lakis, V., Chan, N. L., Lyons, R. J., Blackburn, N., Nguyen, T. H., Chang, C., Masel, A. M., West, N., Boyle, G. M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5253213/v1

Notoginsenoside R1, a Metabolite from Panax notoginseng, Prevents Paclitaxel-Induced Peripheral Neuropathic Pain in Mice

Al-Musailem, M., Masocha, W., & Al‐Romaiyan, A. (2025) · Molecules · doi:10.3390/molecules30173613

Evaluation de l'effet de molécules candidates dans des modèles murins de neuropathies périphériques induites par la chimiothérapie anticancéreuse

Bouchenaki, H. (2020) · doi:10.70675/44b49e72z57c7z47cfzbbabz2b20ae4f21ec

Endocannabinoid system modulation in acute, chronic, and neuropathic pain: reviewing experimental models, clinical evidence, and nanotechnology delivery

Elgohary, R., & Baraka, S. M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01862-4

Cannabidiol attenuates chemotherapy-induced peripheral neuropathic pain through a mechanism that requires the enzyme N -acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD)Preprint

Jesus, C. H. A., Li, A.-L., Luquet, S. H., Mackie, K., & Hohmann, A. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.730909

BindingDB Entry 50000616: Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.

BindingDB (2019) · UC San Diego · doi:10.7270/q2jm2d3v

Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy

Khasabova, I. A., Khasabov, S., Paz, J., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0403-12.2012 · Cited by 129 · see citing works

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment

Guindon, J., Lai, Y., Takacs, S. M., Bradshaw, H. B., & Hohmann, A. G. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.013 · Cited by 160 · see citing works

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

Khasabova, I. A., Khasabov, S. G., Olson, J. K., Uhelski, M. L., Kim, A. H., Albino-Ramírez, A. M., Wagner, C. L., Seybold, V. S., & Simone, D. A. (2018) · Pain · doi:10.1097/j.pain.0000000000001448 · Cited by 72 · see citing works

Effect of Acute and Chronic Administration of Carbamazepine on Cisplatin-Induced Hyperalgesia in Rats

Nayebi, A. M., Sharifi, H., Ramadzani, M., & Rezazadeh, H. (2012) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.17795/jjnpp-3559 · Cited by 8 · see citing works

Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy

Vera, G., Cabezos, P. A., Martín, M. I., & Abalo, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.02.008 · Cited by 68 · see citing works